MusclePharm Secures Prime Placement at 1,700 GNC Locations for its MuscleGel Product

May 2, 2011

DENVER, May 2, 2011 /PRNewswire/ — MusclePharm Corporation, a Nevada corporation (“MusclePharm” or the “Company”) (OTCBB: MSLP), an expanding U.S. nutritional supplement company, is pleased to announce that it has secured prime placement in 1,700 General Nutrition Center (GNC) locations for its innovative MuscleGel product beginning in August.

MusclePharm will receive L-Box Placement at each GNC location, which is the premier product placement location in each store, to showcase its category-creating supplement, MuscleGel.

The nutritional supplement, which has drawn rave reviews across several different platforms, contains 22 grams of protein and just 96 calories in each pack, and its gel-based formula makes it simple to consume on the go without liquids or mixing.

“This is a great sign that our relationship with GNC is getting stronger by the day. We had an incredible first quarter of 2011 and we are looking forward to even bigger things with them for the rest of 2011 and 2012,” MusclePharm CEO Brad Pyatt said.

In addition to obtaining L-Box Placement at 1,700 GNC locations, MusclePharm is also excited to note that it just came off a record month of approximately $1.8 million in unaudited revenues to start its second quarter. It is a further sign that the popular company continues to expand and develop at a remarkable rate.

“This type of placement is another indication of our incredible growth,” Pyatt said. “It is our goal to deliver remarkable sales and growth, and we will continue to add value to this company.”

GNC is the largest specialty retailer of nutritional products in the world, featuring locations throughout the United States and in numerous international markets.

Its L-Box Placement is reserved for top-selling companies and products, which also indicates the strong business that MusclePharm and MuscleGel is doing at each GNC location.


Headquartered in Denver, Colorado, MusclePharm is a healthy life-style company that develops and manufactures a full line of National Science Foundation approved nutritional supplements that are 100% free of banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts, and Major League Baseball. The Company’s products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe. MusclePharm products are also sold in over 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com.


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Investor Contact:
Cory Gregory

SOURCE MusclePharm Corporation

Source: newswire

comments powered by Disqus